首页> 美国卫生研究院文献>Clinical Molecular Pathology >Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates.
【2h】

Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates.

机译:灵敏的荧光原位杂交方法用于表征骨髓抽吸物中的乳腺癌细胞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: The presence of malignant cells in the blood and bone marrow of patients with cancer at the time of surgery may be indicative of early relapse. In addition to their numbers, the phenotypes of the micrometastatic cells might be essential in determining whether overt metastases will develop. This study aimed to establish a sensitive method for the detection and characterisation of malignant cells present in bone marrow. METHODS: In spiking experiments, SKBR3 cells were mixed with mononuclear cells in known proportions to mimic bone marrow samples with micrometastatic cells. Tumour cells were extracted using SAM-M450 Dynabeads coupled to the MOC-31 anti-epithelial antibody, and were further analysed for amplification of erbB2 and int2 by fluorescent in situ hybridisation (FISH). erbB2 and int2 copy numbers were also determined in 15 primary breast cancers, and bone marrow samples from patients with amplification were analysed for micrometastatic cells by immunomagnetic enrichment and FISH. RESULTS: In model experiments, cells with amplification could be detected in bead selected fractions when ratios of tumour cells (SKBR3) to mononuclear cells were as low as 10:10(7). Among the tumour samples, eight showed increased copy numbers of erbB2 and/or int2, and three of these patients had detectable numbers of tumour cells in their bone marrow: 4000, 540, and 26 tumour cells/10(7) mononuclear cells, respectively. The patient with 540 tumour cells/10(7) mononuclear cells showed high level amplification of erbB2 and suffered from a particularly aggressive disease, whereas the patient with 4000 tumour cells/10(7) mononuclear cells had favourable disease progression. CONCLUSION: These results demonstrate the feasibility and advantage of combining immunomagnetic selection and FISH characterisation of cancer cells in bone marrow samples. It is possible that molecular characterisation of such cells could provide prognostically valuable information.
机译:目的:手术时癌症患者血液和骨髓中存在恶性细胞可能预示着早期复发。除其数目外,微转移细胞的表型可能对于确定是否会发生明显的转移至关重要。这项研究旨在建立一种检测和表征骨髓中恶性细胞的灵敏方法。方法:在加标实验中,将SKBR3细胞与单核细胞按已知比例混合,以模拟具有微转移细胞的骨髓样品。使用与MOC-31抗上皮抗体偶联的SAM-M450 Dynabeads提取肿瘤细胞,并通过荧光原位杂交(FISH)进一步分析erbB2和int2的扩增。还确定了15例原发性乳腺癌的erbB2和int2拷贝数,并通过免疫磁富集和FISH分析了扩增患者的骨髓样品中的微转移细胞。结果:在模型实验中,当肿瘤细胞(SKBR3)与单核细胞的比例低至10:10(7)时,可以在珠选择的级分中检测到具有扩增的细胞。在这些肿瘤样本中,有八个显示出erbB2和/或int2的拷贝数增加,并且其中三个患者的骨髓中可检测到的肿瘤细胞数量分别为4000、540和26个肿瘤细胞/ 10(7)单核细胞。 。具有540个肿瘤细胞/ 10(7)单核细胞的患者显示erbB2的高水平扩增,并患有特别侵袭性的疾病,而具有4000个肿瘤细胞/ 10(7)单个核细胞的患者的疾病进展良好。结论:这些结果证明了结合免疫磁选择和骨髓样品中癌细胞的FISH表征的可行性和优势。此类细胞的分子表征可能会提供预后有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号